斯蒂芬斯重申了联合健康集团（纽约证券交易所代码：UNH）的评级|Group_新浪财经

UnitedHealth Group (NYSE:UNH – Get Rating)'s stock had its "overweight" rating reiterated by investment analysts at Stephens in a note issued to investors on Tuesday, Benzinga reports. They presently have a $605.00 target price on the healthcare conglomerate's stock. Stephens' target price indicates a potential upside of 27.31% from the stock's current price.

Other equities research analysts have also recently issued research reports about the stock. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $615.00 to $617.00 and gave the company a "buy" rating in a report on Tuesday, January 24th. UBS Group dropped their target price on shares of UnitedHealth Group from $590.00 to $550.00 and set a "neutral" rating on the stock in a report on Wednesday, January 18th. Raymond James cut shares of UnitedHealth Group from a "strong-buy" rating to an "outperform" rating and set a $615.00 target price on the stock. in a report on Monday, November 21st. Morgan Stanley restated an "overweight" rating and issued a $587.00 target price on shares of UnitedHealth Group in a report on Wednesday, November 23rd. Finally, Loop Capital increased their price target on shares of UnitedHealth Group from $575.00 to $590.00 in a research report on Tuesday, January 17th. Three research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $599.68.

Get

UnitedHealth Group

alerts:

UnitedHealth Group Price Performance

UNH stock opened at $475.22 on Tuesday. UnitedHealth Group has a 1 year low of $449.70 and a 1 year high of $558.10. The company has a market cap of $443.31 billion, a P/E ratio of 22.43, a PEG ratio of 1.36 and a beta of 0.69. The firm has a 50-day moving average of $495.29 and a 200 day moving average of $516.48. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.77 and a quick ratio of 0.82.

UnitedHealth Group (NYSE:UNH – Get Rating) last announced its earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 earnings per share for the quarter, beating analysts' consensus estimates of $5.17 by $0.17. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. The business had revenue of $82.79 billion during the quarter, compared to the consensus estimate of $82.53 billion. During the same quarter last year, the firm earned $4.48 earnings per share. The business's revenue for the quarter was up 12.3% on a year-over-year basis. On average, sell-side analysts forecast that UnitedHealth Group will post 24.91 EPS for the current year.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 450 shares of UnitedHealth Group stock in a transaction on Wednesday, December 7th. The shares were sold at an average price of $542.30, for a total value of $244,035.00. Following the completion of the transaction, the executive vice president now directly owns 8,736 shares of the company's stock, valued at approximately $4,737,532.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.40% of the company's stock.

Hedge Funds Weigh In On UnitedHealth Group

A number of large investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of UnitedHealth Group by 1.0% during the 3rd quarter. Vanguard Group Inc. now owns 82,969,869 shares of the healthcare conglomerate's stock worth $41,903,103,000 after purchasing an additional 851,994 shares during the period. FMR LLC boosted its position in UnitedHealth Group by 2.0% in the 2nd quarter. FMR LLC now owns 49,813,470 shares of the healthcare conglomerate's stock valued at $25,585,693,000 after buying an additional 998,214 shares during the period. Price T Rowe Associates Inc. MD boosted its position in UnitedHealth Group by 17.8% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 36,853,394 shares of the healthcare conglomerate's stock valued at $18,929,009,000 after buying an additional 5,556,335 shares during the period. Geode Capital Management LLC boosted its position in UnitedHealth Group by 1.5% in the 4th quarter. Geode Capital Management LLC now owns 16,858,436 shares of the healthcare conglomerate's stock valued at $8,921,651,000 after buying an additional 247,997 shares during the period. Finally, Morgan Stanley boosted its position in UnitedHealth Group by 13.8% in the 4th quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate's stock valued at $8,289,386,000 after buying an additional 1,893,192 shares during the period. 86.31% of the stock is owned by hedge funds and other institutional investors.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
Jack in the Box Pops On Tasty Results, Robust Outlook
How Low Can Lowe's Companies Go?
Ambarella: An AI Play In The Making
Terran Orbital's New $2.4 Billion Contract is a Game Changer
Wendy's Price Firms After Sizzling Quarter And Juicy Outlook

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.